Ebola Drug From Japan May Emerge Among Key Candidates
This article is for subscribers only.
U.S. government researchers are working hard to get an experimental flu drug from Japan’s Fujifilm Holdings Corp. quickly approved to treat Ebola, as the death toll rises in West Africa.
Fujifilm’s U.S. partner MediVector Inc. in Boston is in talks with the Food and Drug Administration to submit an application to use the drug in humans for Ebola, according to Department of Defense spokeswoman Amy Derrick-Frost. If successful, the treatment drug would be one of the first allowed by U.S. regulators to fight the disease in humans.